Dr. Reshan Fernando manages analytical chemistry and pharmaceutics research at RTI and serves as the principal investigator for the National Toxicology Program’s (NTP’s) Analytical Chemistry Services contract. His work involves characterization of substances being tested for toxicity or carcinogenesis, method development, method validation, and analysis of dosage formulations and biological samples. His work also includes managing biochemical and metals analysis support for a malaria vaccine development program funded by the National Institute of Allergy and Infectious Diseases.
Dr. Fernando has served as Task Leader on many multidisciplinary projects with agency partners, including the New England Bladder Cancer Study, an arsenic exposure study in PIMA Indians, the National Health and Nutrition Examination Survey (NHANES), the National Human Exposure Assessment Survey (NHEXAS), and on the NHEXAS-Arizona Study.
Dr. Fernando has served as Study Director for various commercially sponsored programs involving trace metal analysis in a wide variety of environmental, biological, and pharmaceutical sample matrices. He has a broad background in clean room sample preparation techniques for environmental and biological samples, environmental and biological sample analysis using wide a variety of instrumental techniques—atomic absorption, atomic emission, atomic fluorescence, and mass spectrometry, and trace metal speciation.
With more than 20 years of experience in conducting Good Laboratory Practice studies for commercial pharmaceutical clients and governmental agencies, Dr. Fernando has authored or co-authored more than 90 publications and presentations.